NASH PASS clinical trial enrollment initiative gains partner

High Point Clinical Trials Center announced a 3-year collaboration with ProSciento to join NASH PASS as a site partner, according to a press release.
NASH PASS is Prosciento’s program designed to combine select qualified sites and a proprietary methodology to improve enrollment outcomes in nonalcoholic steatohepatitis clinical trials.
As a partner in NASH PASS, High Point Clinical Trials Center (HPCTC) will contribute its pharmacology expertise and resources from its database of prospective clinical study participants evaluated for nonalcoholic fatty liver disease and NASH using transient

Source link

Related posts

Correction: O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit


Methods for diagnosing bile acid malabsorption: a systematic review


Mucosal healing in Crohn’s requires higher Remicade levels postinduction


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy